skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Umbilical cord cell banking-implications for the future

Journal Article · · Toxicology and Applied Pharmacology
 [1]
  1. Cardiff Law School, Cardiff University, Law Building, Museum Avenue, Cardiff CF10 3XJ (United Kingdom)

The first successful cord cell transplant to a sibling with Fanconi's anaemia took place 15 years ago. This proven utility of cord blood led to the establishment of cord blood banks both private and public and there are now nearly 100 cord blood banks worldwide. It is estimated that over 200,000 cord blood units (CBU) are held by the private sector and over 160,000 CBU are registered with the largest public cord blood registry. There is a tension between private cord blood banks, which store CBU for autologous or family use, and public banks, which store CBU for unrelated use and the ethics of private cord blood storage has been questioned. But more general ethical questions also arise regarding ownership, consent, confidentiality, costs and quality standards and patenting. In looking at these ethical issues one also needs to look at potential future use of cord blood stem cells. Up until now cord cells have principally been used in the treatment of paediatric blood and immune disorders. Improvements in cell expansion technology will make CBU more appropriate also for treating adults with such disorders. However, it has also been demonstrated that cord blood stem cells have the capacity to differentiate into other types of cells, neuronal, bone, epithelial and muscle which would have a future role to play in cell therapy and regenerative medicine.

OSTI ID:
20721956
Journal Information:
Toxicology and Applied Pharmacology, Vol. 207, Issue 2,suppl.1; Conference: ICT X 2004: 10. international congress of toxicology: Living in a safe chemical world, Tampere (Finland), 11-15 Jul 2004; Other Information: DOI: 10.1016/j.taap.2005.01.027; PII: S0041-008X(05)00260-7; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Over-expression of Oct4 and Sox2 transcription factors enhances differentiation of human umbilical cord blood cells in vivo
Journal Article · Fri Sep 05 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:20721956

Neural differentiation of novel multipotent progenitor cells from cryopreserved human umbilical cord blood
Journal Article · Fri Jun 29 00:00:00 EDT 2007 · Biochemical and Biophysical Research Communications · OSTI ID:20721956

Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo
Journal Article · Fri Apr 18 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:20721956